Acevector IPO GMP Today, Price & Details
Acevector IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Acevector
Acevector is making its debut on the Mainboard of the NSE, aiming to raise capital through an Initial Public Offering (IPO). The company operates in a dynamic sector, and this public offering presents an opportunity for investors to participate in its growth journey. The IPO structure includes both a fresh issue and an offer for sale, indicating a mix of capital infusion for the company and an exit route for existing shareholders.
Financially, Acevector has demonstrated a notable performance. For the period under review, the company reported revenues of ₹537.67 Cr and a Profit After Tax (PAT) of ₹102.08 Cr. This translates to an Earnings Per Share (EPS) of ₹0.83. The IPO is structured with a total issue size of ₹420 Cr, comprising a fresh issue of ₹287 Cr and an Offer for Sale (OFS) component of ₹133 Cr. This blend aims to fund the company's expansion plans while also providing liquidity to some of its early investors.
The company's competitive positioning and the intended use of the proceeds from the IPO are key factors for potential investors to consider. The fresh capital raised is expected to bolster Acevector's operational capabilities and strategic initiatives. Understanding how the company plans to deploy these funds to enhance its market standing and drive future profitability will be crucial in evaluating the investment proposition. The lead managers for this significant offering are IIFL Capital Services Ltd., CLSA India Pvt.Ltd., and Systematix Corporate Services Ltd., with MUFG Intime India Pvt.Ltd. serving as the registrar.
Acevector IPO — Investment Analysis
Acevector's IPO is priced within a band of ₹30 to ₹32 per share, with a face value of ₹1. The company has reported an Earnings Per Share (EPS) of ₹0.83, which, when considered against the upper price band of ₹32, results in a Price-to-Earnings (P/E) ratio of approximately 38.55x. This valuation, while not excessively high for a growing company, does place it in a segment that requires strong future earnings growth to justify the premium. Investors will need to assess if the company's growth prospects align with this valuation multiple.
Looking at the financial health, Acevector has posted impressive figures. Its revenue stands at ₹537.67 Cr with a PAT of ₹102.08 Cr. This suggests healthy profit margins. While specific EBITDA figures and return ratios like Return on Net Worth (RONW) and Return on Capital Employed (ROCE) are not detailed here, the substantial PAT relative to revenue indicates a well-managed operation. The company appears to be generating significant profits from its operations, which is a positive sign for its financial robustness.
The growth outlook for Acevector appears promising, driven by its operational scale and profitability. However, investors must also consider potential risks. The presence of an OFS component of ₹133 Cr means a portion of the IPO proceeds will go to selling shareholders, which, while common, can sometimes dilute the immediate impact of capital infusion for growth. Furthermore, sector-specific risks and potential challenges in scaling operations further are inherent to any business expansion. The reliance on the stated revenue and PAT figures without more granular financial data like cash flows or debt levels presents a limitation in a comprehensive analysis.
Subscription levels for the IPO will be a key indicator of market sentiment. High subscription from Qualified Institutional Buyers (QIBs) and High Net-worth Individuals (HNIs) often signals strong institutional confidence in the company's long-term prospects. Conversely, robust retail investor interest can suggest broad appeal. Observing these subscription trends will provide insights into how different investor segments perceive Acevector's valuation and growth potential. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Acevector IPO — Pros & Cons
Strengths
- The company has reported a strong revenue of ₹537.67 Cr and a healthy PAT of ₹102.08 Cr. This financial performance indicates robust operational efficiency and profitability, which is a significant positive for potential investors looking for companies with a solid track record.
- The IPO includes a substantial fresh issue component of ₹287 Cr. This infusion of capital is intended to fuel the company's growth initiatives, suggesting a strategic focus on expansion and market strengthening, which can lead to future value creation for shareholders.
- Acevector operates within a sector that likely offers significant growth opportunities, though specific sector details are not provided. A strong financial backing coupled with market potential can create a compelling investment case.
- The company has a reported EPS of ₹0.83, which, combined with its PAT, suggests efficient earnings generation. This metric is crucial for investors evaluating the profitability of the company on a per-share basis.
- The IPO is being managed by reputable lead managers, including IIFL Capital Services Ltd., CLSA India Pvt.Ltd., and Systematix Corporate Services Ltd. This professional guidance can instill confidence in the IPO process and the company's strategic direction.
Risks
- The P/E ratio of approximately 38.55x, based on the upper price band of ₹32 and EPS of ₹0.83, might be considered on the higher side for some investors. This valuation suggests that the market has priced in significant future growth, and any slowdown could impact stock performance.
- The IPO includes an Offer for Sale (OFS) component of ₹133 Cr. While this provides an exit for some existing shareholders, it means a portion of the total issue size does not directly contribute to strengthening the company's balance sheet or funding its expansion plans.
- Detailed financial statements, including EBITDA, cash flow statements, and specific return ratios like RONW and ROCE, are not provided in the data. This lack of granular financial information limits a comprehensive assessment of the company's overall financial health and operational efficiency.
- The data does not specify the exact business sector of Acevector. Without this crucial information, it's challenging to assess industry-specific growth prospects, competitive landscape, and potential regulatory risks that could impact the company.
- The lot size is 468 shares, meaning a minimum investment of ₹14,976 (468 shares * ₹32). This relatively high minimum investment might be a barrier for some retail investors looking to enter the IPO with smaller amounts.
Acevector IPO Details
| Company Name | Acevector |
|---|---|
| IPO Type | MAINBOARD |
| Exchange | NSE |
| Price Band | ₹30 - ₹32 |
| Face Value | ₹1 per share |
| Lot Size | 468 shares |
| Min Investment | ₹14,976 |
| Total Issue Size | ₹420.00 Cr |
|---|---|
| Fresh Issue | ₹287.00 Cr |
| Offer for Sale | ₹133.00 Cr |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Manager | IIFL Capital Services Ltd., CLSA India Pvt.Ltd., Systematix Corporate Services Ltd. |
| IPO Status | Closed |
Acevector IPO Dates
Acevector IPO Subscription Status
Acevector IPO GMP Today
The Grey Market Premium (GMP) for Acevector IPO is ₹2, indicating an expected listing at ₹34 (+6.3% premium).
| Date | GMP (₹) | Est. Listing (₹) | Sauda Rate (₹) | Change |
|---|---|---|---|---|
| 25 Sep 2026 | +₹2 | ₹34 | - | - |
Acevector IPO — Key Highlights
- Acevector has reported a substantial revenue of ₹537.67 Cr and a PAT of ₹102.08 Cr, indicating strong operational performance.
- The IPO issue size stands at a significant ₹420 Cr, with a fresh issue component of ₹287 Cr to fund growth.
- The company's reported EPS is ₹0.83, providing a basis for valuation analysis.
- The P/E ratio at the upper price band is approximately 38.55x, suggesting a growth-focused valuation.
- The IPO lot size is fixed at 468 shares, requiring a minimum investment of ₹14,976.
- The OFS component is ₹133 Cr, offering an exit route for existing shareholders.
Acevector Financial Performance
| Revenue | ₹537.67 Cr |
|---|---|
| PAT | ₹102.08 Cr |
| EPS | ₹0.83 |
Acevector IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹0.83 |
|---|---|
| P/E Ratio | 38.55x |
| Debt/Equity | 0.000 |
Return Metrics
Acevector IPO Reservation / Allocation
Acevector IPO Lead Manager & Registrar
Book Running Lead Manager
IIFL Capital Services Ltd., CLSA India Pvt.Ltd., Systematix Corporate Services Ltd.
IPO Registrar
MUFG Intime India Pvt.Ltd.
Acevector IPO — Frequently Asked Questions
What is Acevector IPO GMP today?
As of today, the Grey Market Premium (GMP) for Acevector IPO is ₹2 per share, indicating a potential listing premium of 6.3% above the issue price of ₹32.
What is the price band and lot size of Acevector IPO?
Acevector IPO has a price band of ₹30 to ₹32 per equity share with a face value of ₹1. The minimum lot size is 468 shares, requiring a minimum investment of ₹14,976 at the upper band.
What are the important dates for Acevector IPO?
Acevector IPO opens for subscription on 25 Sep 2026 and closes on 29 Sep 2026. Allotment is expected on 30 Sep 2026. The shares are expected to list on NSE on 05 Oct 2026.
What is the investor category allocation in Acevector IPO?
The shares are reserved as follows — Qualified Institutional Buyers (QIB): 0.00%, Non-Institutional Investors (NII/HNI): 0.00%, and Retail Individual Investors: 10.00%.
How can I apply for Acevector IPO?
You can apply for Acevector IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is MUFG Intime India Pvt.Ltd..
What is the subscription status of Acevector IPO?
Acevector IPO has been subscribed 8.53 times overall. Retail category: 4.83x, NII/HNI: 8.53x, QIB: 3.42x.
What is Acevector IPO price band and lot size?
The Acevector IPO comes with a price band of ₹30 to ₹32 per share. The face value of each share is ₹1. For retail investors, the minimum lot size is 468 shares, which translates to a minimum investment of ₹14,976 (468 shares x ₹32).
Is Acevector IPO worth investing in?
Acevector presents a mixed picture. On one hand, it boasts strong revenue figures of ₹537.67 Cr and a PAT of ₹102.08 Cr, indicating healthy profitability. The P/E ratio of around 38.55x suggests a growth-oriented valuation.
However, the valuation warrants careful consideration, and the lack of detailed financial metrics like cash flows or specific return ratios limits a complete picture. The presence of an OFS component of ₹133 Cr also means not all funds raised go directly into business expansion. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Acevector IPO GMP today?
Grey Market Premium (GMP) for the Acevector IPO is an unofficial indicator of market sentiment, reflecting the price at which IPO shares are traded before listing. While GMP can provide a glimpse into demand, it's highly speculative and not based on fundamental analysis. Any GMP figures should be treated with caution, as they can fluctuate significantly and are not a guarantee of listing performance.
Investors should not rely solely on GMP for investment decisions.
How to apply for Acevector IPO?
You can apply for the Acevector IPO through either the UPI mechanism or the ASBA (Application Supported by Blocked Amount) facility offered by banks. You'll need to log in to your net banking portal or trading platform and select the IPO option. The registrar for this IPO is MUFG Intime India Pvt.Ltd.
Your funds will remain blocked in your bank account until the allotment process is completed, after which they will either be debited for shares or unblocked.